Prehabilitation Prior to Surgery for Kidney Tumors
Launched by HERLEV AND GENTOFTE HOSPITAL · Dec 17, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether taking one month to improve overall health before surgery for kidney tumors can help patients recover faster and feel better afterward. This process, called prehabilitation, includes a thorough health check, help with quitting smoking, and a personalized exercise program. Participants will be divided into two groups: one group will go through the prehabilitation program, while the other will receive standard care without the additional support.
To be eligible for this trial, participants should be 65 years or older and have a specific type of kidney tumor (cT1) that requires surgery. It’s important that they are generally healthy enough to participate, as determined by a health assessment. During the trial, participants can expect to receive support for their health before surgery and be asked about their recovery experience afterward. This study aims to find out if prehabilitation leads to higher satisfaction and better physical abilities after surgery compared to those who do not participate in the program.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 65 years or older
- • cT1 kidney tumor, scheduled for either partial or radical nephrectomy.
- • Clinical Frailty Scale 3-6
- Exclusion Criteria:
- • It is determined by an attending physician, or at a multi-disciplinary team-conference, that a 2-4 week postponement of surgery will not be beneficial for the participant.
- • Participant does not understand Danish og English
About Herlev And Gentofte Hospital
Herlev and Gentofte Hospital, a leading healthcare institution in Denmark, is dedicated to advancing medical research and patient care through innovative clinical trials. As a prominent sponsor, the hospital focuses on a wide range of therapeutic areas, leveraging its multidisciplinary expertise and state-of-the-art facilities to facilitate rigorous scientific investigation. Committed to enhancing treatment outcomes and improving patient quality of life, Herlev and Gentofte Hospital collaborates with academic institutions and industry partners to foster groundbreaking discoveries and translate research findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Herlev, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported